NO960754L - Farmasöytiske blandinger omfattende metall-komplekser - Google Patents

Farmasöytiske blandinger omfattende metall-komplekser

Info

Publication number
NO960754L
NO960754L NO960754A NO960754A NO960754L NO 960754 L NO960754 L NO 960754L NO 960754 A NO960754 A NO 960754A NO 960754 A NO960754 A NO 960754A NO 960754 L NO960754 L NO 960754L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
metal complexes
complexes
metal
pharmaceutical
Prior art date
Application number
NO960754A
Other languages
English (en)
Other versions
NO960754D0 (no
Inventor
Michael Jeffrey Abrams
Simon Paul Fricker
Barry Anthony Murrer
Owen John Vaughan
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of NO960754D0 publication Critical patent/NO960754D0/no
Publication of NO960754L publication Critical patent/NO960754L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO960754A 1993-08-25 1996-02-23 Farmasöytiske blandinger omfattende metall-komplekser NO960754L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317686A GB9317686D0 (en) 1993-08-25 1993-08-25 Pharmaceutical compositions
PCT/GB1994/001817 WO1995005814A1 (en) 1993-08-25 1994-08-19 Pharmaceutical compositions comprising metal complexes

Publications (2)

Publication Number Publication Date
NO960754D0 NO960754D0 (no) 1996-02-23
NO960754L true NO960754L (no) 1996-04-23

Family

ID=10741021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960754A NO960754L (no) 1993-08-25 1996-02-23 Farmasöytiske blandinger omfattende metall-komplekser

Country Status (14)

Country Link
US (1) US5824673A (no)
EP (1) EP0714294A1 (no)
JP (1) JPH09501927A (no)
KR (1) KR100331978B1 (no)
AU (1) AU698785B2 (no)
CA (1) CA2170253A1 (no)
FI (1) FI960849A (no)
GB (1) GB9317686D0 (no)
HU (1) HUT74947A (no)
NO (1) NO960754L (no)
NZ (1) NZ269596A (no)
TW (1) TW282401B (no)
WO (1) WO1995005814A1 (no)
ZA (1) ZA946262B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417182B1 (en) * 1993-08-25 2002-07-09 Anormed Inc. Pharmaceutical compositions comprising metal complexes
JPH10500129A (ja) 1994-05-11 1998-01-06 ジェス、オルセン 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用
HUT76327A (en) * 1994-05-13 1997-08-28 Monsanto Co Pharmaceutical compositions catalyzing decomposition of peroxy-nitrite
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US6743771B2 (en) * 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
DE19860289C2 (de) * 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
CN1391577A (zh) * 1999-03-19 2003-01-15 阿诺麦德股份有限公司 含金属复合物的药物组合物
EP2284276A1 (en) * 1999-08-25 2011-02-16 Clarity Biosciences, Inc. Identifying organisms by detecting intronic nucleic acid or encoded proteins
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
EP1370679B1 (en) * 2001-03-01 2011-10-05 Clarity Biosciences, Inc. Methods of making and uses of compositions that modulate intronic region-encoded protein function
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
AU2003208525B9 (en) * 2002-02-04 2009-08-27 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
CN1318430C (zh) * 2003-04-24 2007-05-30 钟文远 一类稀土配合物及其制备方法和在制备治疗肿瘤药物中的应用
WO2005044286A1 (ja) * 2003-11-07 2005-05-19 Shetech Co., Ltd. 脳梗塞の予防及び／又は治療のための医薬
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
WO2007064895A2 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US20080119002A1 (en) * 2006-11-17 2008-05-22 Charles Grosjean Substrate contact for a MEMS device
US8597563B2 (en) 2008-07-11 2013-12-03 Rohm And Haas Company Recycled thermoplastic composition comprising waste thermoset material and methods of making
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
WO2012138988A2 (en) * 2011-04-07 2012-10-11 The Research Foundation Of The City University Of New York Organometallic anti-cancer complexes
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1482811A (fr) * 1960-01-26 1967-06-02 Australian Nat University Pers Nouveaux complexes métallifères d'agents de coordination homogènes, et leur procédé de préparation
WO1986000804A1 (en) * 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Ruthenium compositions having a tumor inhibiting activity
JPH0694471B2 (ja) * 1984-07-24 1994-11-24 アスタ・メディカ・アクチエンゲゼルシヤフト 薬理学的に認容性の錯化合物およびその製造法
US5157032A (en) * 1985-01-18 1992-10-20 The Trustees Of Columbia University In The City Of New York Mixed ligand complexes and uses thereof as binding agents and probes to DNA
IT1230145B (it) * 1989-05-05 1991-10-14 Boehringer Biochemia Srl Complessi di rutenio (iii) come agenti antineoplastici.

Also Published As

Publication number Publication date
WO1995005814A1 (en) 1995-03-02
HU9600441D0 (en) 1996-04-29
AU7390794A (en) 1995-03-21
TW282401B (no) 1996-08-01
CA2170253A1 (en) 1995-03-02
AU698785B2 (en) 1998-11-05
JPH09501927A (ja) 1997-02-25
GB9317686D0 (en) 1993-10-13
NZ269596A (en) 1997-05-26
ZA946262B (en) 1995-03-20
NO960754D0 (no) 1996-02-23
HUT74947A (en) 1997-03-28
FI960849A0 (fi) 1996-02-23
US5824673A (en) 1998-10-20
KR100331978B1 (ko) 2002-09-26
FI960849A (fi) 1996-02-23
KR960703609A (ko) 1996-08-31
EP0714294A1 (en) 1996-06-05

Similar Documents

Publication Publication Date Title
NO960754D0 (no) Farmasöytiske blandinger omfattende metall-komplekser
FI955144A0 (fi) Päällystetyt farmaseuttiset koostumukset
FI944832A0 (fi) Farmaseuttinen koostumus
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE69423670D1 (de) Siloxy-aluminoxan-Zusammensetzungen
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
DE69408833D1 (de) Mineralgefüllte copolyamdidzusammensetzungen
FI955311A0 (fi) Farmaseuttinen koostumuspohja
NO944442D0 (no) Metalltetning
ITMI932540A0 (it) Composizione farmaceutica
BR9507768A (pt) Composição farmacêutica
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
DE69325426D1 (de) Lötbare Legierungen
LV10579A (lv) Farmaceitiska kompozicija
FI952377A (fi) Farmaseuttisia ibuprofeenikoostumuksia
NO943538D0 (no) Legeringstilsetning
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI962738A (fi) Farmaseuttiset koostumukset
DK0599461T3 (da) Hærdelige sammensætninger
ITMI932543A0 (it) Composizione farmaceutica
BR1100200A (pt) Composição farmacêutica
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922580A0 (it) Composizione farmaceutica
ITMI922581A0 (it) Composizione farmaceutica
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina